A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
Local recurrence is a common cause of treatment failure for patients with solid tumors. Intraoperative detection of microscopic residual cancer in the tumor bed could be used to decrease the risk of a positive surgical margin, reduce rates of reexcision, and tailor adjuvant therapy. We used a protea...
Similar Items
-
Limb salvage versus amputation in patients with osteosarcoma of the extremities: an update in the modern era using the National Cancer Database
by: Daniel R. Evans, et al.
Published: (2020-10-01) -
Race is an independent predictor of survival in patients with soft tissue sarcoma of the extremities
by: Alexander L. Lazarides, et al.
Published: (2018-04-01) -
Revisiting the Role of Radiation Therapy in Chondrosarcoma: A National Cancer Database Study
by: Anthony A. Catanzano, et al.
Published: (2019-01-01) -
Imaging Primary Mouse Sarcomas After Radiation Therapy Using Cathepsin-Activatable Fluorescent Imaging Agents
by: Cuneo, Kyle C., et al.
Published: (2014) -
A Novel Imaging System Permits Real-time in Vivo Tumor Bed Assessment After Resection of Naturally Occurring Sarcomas in Dogs
by: Eward, William C., et al.
Published: (2017)